BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 36940098)

  • 21. [Efficacy and prognosis analysis in 188 children with acute lymphoblastic leukemia of China].
    Yang MH; Jia WG; Cao LZ; He YL; Liao N; Chen GL; Luo JM; Xu WQ; Yang J
    Zhonghua Er Ke Za Zhi; 2008 Jul; 46(7):498-501. PubMed ID: 19099804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of acute lymphoblastic leukaemia in countries with limited resources; lessons from use of a single protocol in India over a twenty year period [corrected].
    Magrath I; Shanta V; Advani S; Adde M; Arya LS; Banavali S; Bhargava M; Bhatia K; Gutiérrez M; Liewehr D; Pai S; Sagar TG; Venzon D; Raina V
    Eur J Cancer; 2005 Jul; 41(11):1570-83. PubMed ID: 16026693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive factors for adverse outcome of advanced-stage childhood lymphoblastic lymphoma: a single tertiary center retrospective study in Thailand.
    Chavananon S; Sripornsawan P; McNeil EB; Chotsampancharoen T
    Pediatr Hematol Oncol; 2022 Apr; 39(3):233-242. PubMed ID: 34378480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical outcomes and prognostic factors in children with B-cell lymphoblastic lymphoma (LBL) treated according to on modified BFM-90 protocol: Experience from a Tertiary cancer care center in India.
    Vijayasekharan K; Kc A; Prasad M; Dhamne C; Roy Moulik N; Shet T; Sridhar E; Laskar S; Kembhavi S; Shah S; Gujral S; Narula G; Banavali SD
    Pediatr Hematol Oncol; 2022 Aug; 39(5):427-440. PubMed ID: 35179438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Real-world outcomes of treatment for acute lymphoblastic leukemia during adolescence in a financially restricted environment: Results at a single center in Latin America.
    Jaime-Pérez JC; Jiménez-Castillo RA; Pinzón-Uresti MA; Cantú-Rodríguez OG; Herrera-Garza JL; Marfil-Rivera LJ; Gómez-Almaguer D
    Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 27957789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term follow-up of acute lymphoblastic leukemia in young children treated by the SCMC-ALL-2009 protocol.
    Liu K; Chu J; Dai Y; Jiang A; Yang L; Xie Z; Zhang K; Tu S; Cai H; Wu Z; Wang N
    Leuk Lymphoma; 2020 Dec; 61(12):2850-2858. PubMed ID: 32643496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Long-term results of multicenter study based on childhood acute lymphoblastic leukemia 2005 protocol].
    Cai JY; Wang NL; Jiang H; Shen SH; Xue HL; Chen J; Pan C; Gao YJ; Sun LR; Yuan XJ; Gu LJ; Tang JY
    Zhonghua Er Ke Za Zhi; 2018 Jul; 56(7):511-517. PubMed ID: 29996184
    [No Abstract]   [Full Text] [Related]  

  • 28. Good steroid response in vivo predicts a favorable outcome in children with T-cell acute lymphoblastic leukemia. The Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP).
    Aricò M; Basso G; Mandelli F; Rizzari C; Colella R; Barisone E; Zanesco L; Rondelli R; Pession A; Masera G
    Cancer; 1995 Apr; 75(7):1684-93. PubMed ID: 8826928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment for childhood acute lymphoblastic leukemia in Taiwan: Taiwan Pediatric Oncology Group ALL-2002 study emphasizing optimal reinduction therapy and central nervous system preventive therapy without cranial radiation.
    Li MJ; Liu HC; Yen HJ; Jaing TH; Lin DT; Yang CP; Lin KH; Hung IJ; Jou ST; Lu MY; Hsiao CC; Peng CT; Chang TT; Wang SC; Lin MT; Chen JS; Chang TK; Hung GY; Wu KH; Yang YL; Chang HH; Chen SH; Yeh TC; Cheng CN; Lin PC; Chiou SS; Sheen JM; Cheng SN; Chen SH; Chang YH; Ho WL; Chao YH; Chen RL; Chen BW; Wang JL; Hsieh YL; Liao YM; Yang SH; Chang WH; Chao YY; Liang DC
    Pediatr Blood Cancer; 2017 Feb; 64(2):234-241. PubMed ID: 27696656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical effect of CCLG-ALL2008 regimen in treatment of children and adolescents aged >10 years with acute lymphoblastic leukemia].
    Lan Y; Chen XJ; Zou Y; Ruan M; Zhu XF
    Zhongguo Dang Dai Er Ke Za Zhi; 2019 May; 21(5):405-410. PubMed ID: 31104652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pediatric acute leukemia: the effect of prognostic factors on clinical outcomes at Phramongkutklao Hospital, Bangkok, Thailand.
    Rujkijyanont P; Kaewinsang S; Monsereenusorn C; Traivaree C
    J Med Assoc Thai; 2014 Feb; 97 Suppl 2():S188-95. PubMed ID: 25518193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival outcomes of myeloid leukemia associated with Down syndrome and de novo acute myeloid leukemia in children: Experience from a single tertiary center in Thailand.
    Songthawee N; Sripornsawan P; Chavananon S; Kittivisuit S; McNeil EB; Chotsampancharoen T
    Pediatr Hematol Oncol; 2024; 41(2):150-162. PubMed ID: 38013232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ETV6/RUNX1-positive childhood acute lymphoblastic leukemia in China: excellent prognosis with improved BFM protocol.
    Wang Y; Zeng HM; Zhang LP
    Ital J Pediatr; 2018 Aug; 44(1):94. PubMed ID: 30115129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Analysis of therapy results and prognostic factors in children with acute lymphoblastic leukaemia in Warmia and Mazury region: 17-years experience].
    Badowska W
    Med Wieku Rozwoj; 2008; 12(4 Pt 2):1001-7. PubMed ID: 19531816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A collaborative study of children with lymphoblastic non-Hodgkin's lymphoma in China].
    ;
    Zhonghua Er Ke Za Zhi; 2015 Dec; 53(12):931-7. PubMed ID: 26887549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of sex in childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study.
    Shuster JJ; Wacker P; Pullen J; Humbert J; Land VJ; Mahoney DH; Lauer S; Look AT; Borowitz MJ; Carroll AJ; Camitta B
    J Clin Oncol; 1998 Aug; 16(8):2854-63. PubMed ID: 9704739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of childhood acute lymphoblastic leukemia in Iraq: a 17-year experience from a single center.
    Al-Hadad SA; Al-Jadiry MF; Ghali HH; Al-Badri SAF; Al-Saeed RM; Al-Darraji AF; Sabhan AH; Fadhil SA; Hussein HM; Abed WM; Ameen NA; Sahan JKA; Jaafar GQ; Abed AR; Mohamed S; Moleti ML; Piciocchi A; Foà R; Testi AM
    Leuk Lymphoma; 2021 Dec; 62(14):3430-3439. PubMed ID: 34355644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prognostic factors of pediatric patients with Ph-positive acute lymphoblastic leukemia].
    Xue YJ; Wu J; Zuo YX; Jia YP; Lu AD; Zhang LP
    Zhonghua Xue Ye Xue Za Zhi; 2018 Mar; 39(3):219-224. PubMed ID: 29562467
    [No Abstract]   [Full Text] [Related]  

  • 39. [Monitoring of minimal residual disease in children with acute lymphoblastic leukemia and its prognostic significance].
    Xu XJ; Tang YM; Song H; Shi SW; Yang SL; Shen HQ; Wei J; Xu WQ; Pan BH; Zhao FY
    Zhonghua Er Ke Za Zhi; 2010 Mar; 48(3):180-4. PubMed ID: 20426951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical presentation, hematologic features and treatment outcome of childhood acute lymphoblastic leukemia: a review of 73 cases in Hong Kong.
    Ma SK; Chan GC; Ha SY; Chiu DC; Lau YL; Chan LC
    Hematol Oncol; 1997 Aug; 15(3):141-9. PubMed ID: 9600113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.